Subtopic Deep Dive
Familial Hemophagocytic Lymphohistiocytosis Genetic Mutations
Research Guide
What is Familial Hemophagocytic Lymphohistiocytosis Genetic Mutations?
Familial Hemophagocytic Lymphohistiocytosis (FHLH) genetic mutations are inherited defects in genes such as PRF1 and UNC13D that impair cytotoxic lymphocyte function, leading to uncontrolled immune activation and hyperinflammation.
FHLH represents the genetic form of hemophagocytic lymphohistiocytosis (HLH), distinguished from secondary forms by mutations causing defective perforin-mediated cytotoxicity (Jordan et al., 2004; 699 citations). Key genes include PRF1, UNC13D, and STX11, with genotype-phenotype correlations guiding diagnosis and transplantation decisions (Janka, 2011; 541 citations). Over 10 papers in the provided list detail FHLH mechanisms and treatment outcomes.
Why It Matters
Genetic identification of FHLH mutations enables prenatal screening and risk stratification for hematopoietic stem cell transplantation, improving survival from <20% to over 50% in treated cohorts (Trottestam et al., 2011; 658 citations). Jordan et al. (2011; 1111 citations) outline mutation-specific therapies, reducing reliance on empiric chemoimmunotherapy like HLH-94 protocols. Janka (2011) emphasizes how PRF1 mutations predict early-onset disease, informing family counseling and targeted IFN-γ blockade as in emapalumab trials (Locatelli et al., 2020; 471 citations).
Key Research Challenges
Genotype-Phenotype Correlation
Mapping specific mutations like PRF1 null alleles to disease onset and severity remains incomplete. Jordan et al. (2004; 699 citations) link perforin defects to cytotoxicity failure, but variable expressivity complicates predictions. Larger genomic cohorts are needed for precise correlations (Janka, 2011).
Mutation Spectrum Diversity
Over 100 FHLH mutations across PRF1, UNC13D, and STX11 show ethnic variability and incomplete penetrance. Janka (2011; 541 citations) reviews familial cases but highlights gaps in non-European populations. Comprehensive sequencing is required for full spectra.
Transplantation Outcome Prediction
Pre-transplant mutation profiling fails to reliably predict graft success or relapse risk. Trottestam et al. (2011; 658 citations) report HLH-94 outcomes, yet genetic factors influencing engraftment are unclear. Bergsten et al. (2017; 620 citations) call for integrated genetic prognostic models.
Essential Papers
How I treat hemophagocytic lymphohistiocytosis
Michael B. Jordan, Carl E. Allen, Sheila Weitzman et al. · 2011 · Blood · 1.1K citations
Abstract Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation, occurring as either a familial disorder or a sporadic condition, in association with a variety of tr...
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy, Gökhan Keser, Pamir Atagündüz et al. · 2020 · Clinical Rheumatology · 833 citations
Our manuscrip is about cytokine storm occuring in the course of COVID-19. It is a rewiev and We did not use any official patient data for this publication.
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
Michael B. Jordan, David A. Hildeman, John W. Kappler et al. · 2004 · Blood · 699 citations
Abstract Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder with familial and acquired forms. The familial form is associated with mutations in the perforin gene and both forms are associa...
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
Helena Trottestam, AnnaCarin Horne, Maurizio Aricò et al. · 2011 · Blood · 658 citations
Abstract Hemophagocytic lymphohistiocytosis (HLH) used to have a dismal prognosis. We report the final results of HLH-94, the largest prospective diagnostic/therapeutic HLH study so far. The treatm...
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study
Elisabet Bergsten, AnnaCarin Horne, Maurizio Aricò et al. · 2017 · Blood · 620 citations
Key Points Early introduction of cyclosporine did not improve HLH outcome in patients treated with the HLH-94 etoposide-dexamethasone backbone (P = .06). HLH-2004 may be improved by risk-group stra...
Infections associated with haemophagocytic syndrome
Nadine Rouphael, Naasha J Talati, Camille P. Vaughan et al. · 2007 · The Lancet Infectious Diseases · 575 citations
Interleukin‐18: Biological properties and role in disease pathogenesis
Gilles Kaplanski · 2017 · Immunological Reviews · 572 citations
Summary Initially described as an interferon ( IFN )γ‐inducing factor, interleukin (IL)‐18 is indeed involved in Th1 and NK cell activation, but also in Th2, IL ‐17‐producing γδ T cells and macroph...
Reading Guide
Foundational Papers
Start with Jordan et al. (2011; 1111 citations) for clinical overview distinguishing familial HLH; follow with Jordan et al. (2004; 699 citations) for PRF1 mutation mechanisms in animal models; Janka (2011; 541 citations) details FHLH genetics.
Recent Advances
Locatelli et al. (2020; 471 citations) on emapalumab for primary HLH; Bergsten et al. (2017; 620 citations) on HLH-2004 refining mutation-informed therapy.
Core Methods
Genetic sequencing of PRF1/UNC13D; cytotoxicity assays (NK/degranulation); HLH protocols (HLH-94/2004 etoposide-dexamethasone); IFN-γ blockade trials.
How PapersFlow Helps You Research Familial Hemophagocytic Lymphohistiocytosis Genetic Mutations
Discover & Search
Research Agent uses searchPapers and citationGraph to map FHLH mutation literature from Jordan et al. (2011; 1111 citations), revealing PRF1/UNC13D clusters. exaSearch uncovers rare STX11 variants; findSimilarPapers extends to 250M+ OpenAlex papers on genotype-phenotype links.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation data from Janka (2011), then verifyResponse with CoVe checks claims against HLH-94 results (Trottestam et al., 2011). runPythonAnalysis performs GRADE grading on survival stats and pandas-based mutation frequency analysis from abstracts.
Synthesize & Write
Synthesis Agent detects gaps in UNC13D phenotype studies via contradiction flagging across Jordan (2004) and Locatelli (2020). Writing Agent uses latexEditText, latexSyncCitations for HSCT protocol drafts, and latexCompile for publication-ready reviews with exportMermaid for mutation pathway diagrams.
Use Cases
"Analyze PRF1 mutation frequencies in FHLH cohorts from top papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas counts mutations from Jordan 2004/2011 abstracts) → CSV export of allele frequencies and penetrance stats.
"Draft LaTeX review on FHLH genotype-HSCT correlations"
Synthesis Agent → gap detection (Janka 2011 + Bergsten 2017) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → PDF with cited survival curves.
"Find code for HLH genetic simulation models"
Research Agent → paperExtractUrls (Jordan 2004) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for cytotoxicity modeling.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ FHLH papers: searchPapers → citationGraph (Jordan 2011 hub) → structured report on mutation spectra. DeepScan analyzes HLH-94 data (Trottestam 2011) via 7-step CoVe with runPythonAnalysis checkpoints for treatment efficacy. Theorizer generates hypotheses on STX11 modifiers from Janka (2011) literature synthesis.
Frequently Asked Questions
What defines Familial Hemophagocytic Lymphohistiocytosis genetic mutations?
FHLH mutations occur in PRF1, UNC13D, STX11 impairing NK/CD8 cytotoxicity, causing hyperinflammation (Janka, 2011; Jordan et al., 2004).
What are key methods for studying FHLH mutations?
Sanger/next-gen sequencing identifies variants; perforin expression assays confirm function loss; animal models validate via CD8/IFN-γ knockout (Jordan et al., 2004).
What are the most cited papers on FHLH mutations?
Jordan et al. (2011; 1111 citations) on treatment; Jordan et al. (2004; 699 citations) on perforin models; Janka (2011; 541 citations) on familial forms.
What open problems exist in FHLH mutation research?
Unresolved: incomplete penetrance mechanisms, ethnic mutation spectra, and genetic predictors of HSCT success (Bergsten et al., 2017; Janka, 2011).
Research Autoimmune and Inflammatory Disorders Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Familial Hemophagocytic Lymphohistiocytosis Genetic Mutations with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers